Terms & conditions

Terms & conditions

This website is designed in the United Kingdom and is for information purposes only and is not an advertisement. Nothing on this site constitutes a binding offer to perform any service.

Although we have taken care over what is said in this website, any advice contained in the website is of a generic nature only. Any reliance by you on such advice or any information in the site is entirely at your own risk and we do not accept any liability to any person who relies on it.

We are not responsible for the content of any other site (website, blog, social media or other), including any site through which you may have gained access to this website or to which you may gain access from this website. We do not accept any liability in connection with any such sites or links.

Copyright

You are responsible for obeying all applicable copyright laws. We permit you to make copies of this site as necessary incidental acts during your viewing of it; and you may take a print for your personal use of so much of the site as is reasonable for private purposes, but you must not otherwise copy it, use it or re-publish it in whole or in part (including by linking or framing) without this “Disclaimer” section nor without first obtaining written consent from I C Consultants Ltd.

© I C Consultants Ltd. All rights reserved, and all moral rights are asserted and reserved.

Latest news, insights and events

Press Release: Imperial team join IfM Engage consortium to boost UK semiconductor sector

Press Release: Imperial team join IfM Engage consortium to boost UK semiconductor sector

Team from Imperial join IfM Engage consortium, commissioned by the Department for Science, Innovation & Technology (DSIT), for a study into infrastructure to grow the UK semiconductor industry - and a new strategic coordination function for the sector. read more

Cystic Fibrosis expert from Imperial named on clinical advisory board for Proteostasis Therapeutics

Cystic Fibrosis expert from Imperial named on clinical advisory board for Proteostasis Therapeutics

Professor Jane Davies of Imperial College London has been appointed to Proteostasis Therapeutics’ Cystic Fibrosis clinical advisory board, in a collaboration facilitated by Imperial Consultants (ICON). read more

Imperial’s new COVID-19 testing lab goes live

Imperial’s new COVID-19 testing lab goes live

Imperial’s contribution to the Testing Alliance launched. Includes the UKAS accredited Molecular Diagnostic Unit (MDU) and existing high-throughput robotic platform for RNA extraction. read more